Office of the Director, National Institutes of Health; Notice of Meeting, 77874 [2024-21838]
Download as PDF
<![CDATA[
77874
Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total annual
burden hours
Form name
Type of respondent
Data Management and Sharing Plan (Part of
Final RPPR).
Recipient .......................
8,621
1
2
17,242
Reporting Burden Total .................................
.......................................
........................
........................
........................
629,088
Recording Keeping
SBIR/STTR Life Cycle Certification ......................
Recipient .......................
1,500
1
15/60
375
Grand Total ....................................................
.......................................
236,226
430,272
........................
629,463
Dated: September 16, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–21802 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NIH Clinical Center
Research Hospital Board.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: October 18, 2024.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: NIH and Clinical Center (CC)
Leadership Announcements, CC CEO Update
of Recent Activities and Organizational
Priorities, Status Report on Key CC Strategic
Plan Initiatives, and Other Business of the
Clinical Center Research Hospital Board
(CCRHB).
Place: National Institutes of Health,
Building 31, Conference Room 6C02 A & B,
9000 Rockville Pike, Bethesda, MD 20892 (InPerson and Virtual)
Contact Persons:
Patricia Piringer, RN, MSN (C), National
Institutes of Health Clinical Center, 10 Center
Drive, Bethesda, MD 20892 ppiringer@
cc.nih.gov, (301) 402–2435, (202) 460–7542
(direct).
VerDate Sep<11>2014
18:07 Sep 23, 2024
Jkt 262001
Natascha Pointer, Management Analyst,
Executive Assistant to Dr. Gilman Office of
the Chief Executive Officer, National
Institutes of Health Clinical Center, 10 Center
Drive, Bethesda, MD 20892, npointer@
cc.nih.gov, (301) 496–4114, (301) 402–2434
(direct).
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person(s) listed
on this notice. The statement should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the CCRHB
website: https://www.ccrhb.od.nih.gov/
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21838 Filed 9–23–24; 8:45 am]
[FR Doc. 2024–21738 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 9990
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Palliative
Care Research Consortium.
Date: November 7, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging, 5601
Fishers Lane, Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Janetta Lun, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institutes of Health, 5601
Fishers Lane, Rm. 213, Rockville, MD 20814,
(301) 496–9666, janetta.lun@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 89, Number 185 (Tuesday, September 24, 2024)]
[Notices]
[Page 77874]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21838]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the NIH Clinical Center
Research Hospital Board.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The meeting can
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: October 18, 2024.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: NIH and Clinical Center (CC) Leadership Announcements,
CC CEO Update of Recent Activities and Organizational Priorities,
Status Report on Key CC Strategic Plan Initiatives, and Other
Business of the Clinical Center Research Hospital Board (CCRHB).
Place: National Institutes of Health, Building 31, Conference
Room 6C02 A & B, 9000 Rockville Pike, Bethesda, MD 20892 (In-Person
and Virtual)
Contact Persons:
Patricia Piringer, RN, MSN (C), National Institutes of Health
Clinical Center, 10 Center Drive, Bethesda, MD 20892
[email protected], (301) 402-2435, (202) 460-7542 (direct).
Natascha Pointer, Management Analyst, Executive Assistant to Dr.
Gilman Office of the Chief Executive Officer, National Institutes of
Health Clinical Center, 10 Center Drive, Bethesda, MD 20892,
[email protected], (301) 496-4114, (301) 402-2434 (direct).
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person(s)
listed on this notice. The statement should include the name,
address, telephone number and, when applicable, the business or
professional affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the CCRHB website: https://www.ccrhb.od.nih.gov/ where an agenda and any additional information
for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-21838 Filed 9-23-24; 8:45 am]
BILLING CODE 4140-01-P
